Recurrent Pregnancy Loss

Chapter

Abstract

Although many advances in reproductive medicine have been made during the past 25 years, miscarriages remain the most common complication of pregnancy. While most miscarriages are sporadic and not repetitive, there is a subset of couples that suffer recurrent miscarriage. In the past, the definition of recurrent pregnancy loss was considered to be three or more miscarriages. A short time ago, the American Society for Reproductive Medicine published a change of definition of recurrent pregnancy loss: “Recurrent pregnancy loss is a disease distinct from infertility, defined by 2 or more failed pregnancies”. Historically, the cause of recurrent pregnancy loss was unknown in most couples. More recently, however, much progress has been made in understanding the mechanisms involved. Two major reasons for recurrent pregnancy loss exist. One is that there is a problem with the pregnancy itself that prohibits the pregnancy from growing properly. The other reason is a problem within the uterine environment that does not allow an otherwise normal embryo to grow properly.

Keywords

Recurrent pregnancy loss Uterine environment Anatomic Hormonal Immunologic Thrombophilic Treatment Miscarriage 

References

  1. 1.
    Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. 2008;90:60S.Google Scholar
  2. 2.
    Clark DA, Daya S, Coulam CB, Gunby J, Recurrent Miscarriage lmmunotherapy Trialists Group. Implication of abnormal human trophoblast karyotype for the evidence-based approach to the understanding, investigation, and treatment of recurrent spontaneous abortion. Am J Reprod lmmunol. 1996;35:495–8.CrossRefGoogle Scholar
  3. 3.
    Kirk EP, Chuong CJ, Coulam CB, Williams TJ. Pregnancy after metroplasty for uterine anomalies. Fertil Steril. 1993;59(6):1164–8.CrossRefGoogle Scholar
  4. 4.
    Peters AJ, Lloyd RP, Coulam CB. Prevalence of out-of-phase endometrial biopsy specimens. Am J Obstet Gynecol. 1992;166:1738–45.CrossRefGoogle Scholar
  5. 5.
    Pratt D, Novonty M, Kaberlein G, et al. Antithyroid antibodies and the association with nonorgan specific antibodies in recurrent pregnancy loss. Am J Obstet Gynecol. 1993;168:837–41.CrossRefGoogle Scholar
  6. 6.
    Temple R, Aldridge V, Greenwood R, Heyburn P, Sampson M, Stanley K. Association between outcome of pregnancy and glycaemic control in early pregnancy in type I diabetes: population based study. BMJ. 2002;325:1275–6.CrossRefGoogle Scholar
  7. 7.
    Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L. Metformin-induced resumption of normal menses in 39 of 43 (91%)previously amenorrheic women with polycystic ovary syndrome. Metabolism. 1999;48:1–10.CrossRefGoogle Scholar
  8. 8.
    Coulam CB, Stephenson M, Stem JJ, Clark DA. Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials. Am J Reprod lmmunol. 1996;35:352–9.CrossRefGoogle Scholar
  9. 9.
    Regan L, Rai R. Thrombophilia and pregnancy loss. J Reprod Immunol. 2002;55:163–80.CrossRefGoogle Scholar
  10. 10.
    Hiller E, Pihusch R. Thrombophilia caused by congenital disorders of blood coagulation. Semin Thromb Hemost. 1998;116:26–32.Google Scholar
  11. 11.
    Goodman CS, Coulam CB, Jeyendran RS, Acosta VA, Roussev R. 2006Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod lmmunol. 2006;56:230–6.CrossRefGoogle Scholar
  12. 12.
    Coulam CB, Jeyendran RS, Fishel LA, Roussev RG. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage. Am J Reprod Immunol. 2006;55:60–368.CrossRefGoogle Scholar
  13. 13.
    Visser JA, de Jong FH, Laven JSE, Themmen APN. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction. 2006;131:1–9.CrossRefGoogle Scholar
  14. 14.
    Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMRI gene to ovarian reserve parameters FSH and anti-Mullerian hormone. Fertil Steril. 2009;91:1700–6.CrossRefGoogle Scholar
  15. 15.
    Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence. IL different genotype and phenotype for genetic and autoimmune etiologies. Fertil Steril. 2009;91:1707–11.CrossRefGoogle Scholar
  16. 16.
    Coulam CB. Immunotherapy for recurrent spontaneous abortion. Early Pregnancy. 1995;1:1–13.Google Scholar
  17. 17.
    Kutteh WH. Antiphospholipid-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low dose aspirin alone. Am J Obstet Gynecol. 1996;174:1584–9.CrossRefGoogle Scholar
  18. 18.
    Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J. 1997;314:253–7.CrossRefGoogle Scholar
  19. 19.
    Cowchock FS, Reece EA, Balaban D, Branch OW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol. 1992;166:1318–23.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Reproductive Medicine InstituteEvanstonUSA
  2. 2.Advocate Sherman HospitalElginUSA

Personalised recommendations